Results were reviewed and interpreted by all authors and all authors were involved in Results: Two applications were identified: telemedicine to facilitate video conferencing as an alternative to outpatient consultations and telehealth monitoring for patients with respiratory failure. One randomised controlled trial using telehealth in patients with respiratory failure including 22 patients with ALS was identified.
Introduction
Management of a patient with amytrophic lateral sclerosis (ALS) aims to improve quality of life and survival. Riluzole and non-invasive ventilation (NIV) can prolong life but attendance at a specialist multidisciplinary ALS clinic is also independently associated with improved survival and quality of life although the reasons for this are uncertain (1) (2) (3) (4) (5) . Patients must travel to access these specialist services that are usually based in cities. These services often differ from those available locally, particularly in rural areas. Given the low prevalence of ALS (approximately 5.4 per 100 000) specialists cover a large geographical area and as a result, much of the day-to-day care is provided by non-specialists (6, 7) . In Scotland for example, six specialist nurses care for 300-400 patients covering an area of over 78 000km 2 (8) . Lack of expertise and limited access to specialist staff and equipment causes patients and their carers to experience significant difficulties (9-14). Whilst in the UK approximately 70% of patients attend a specialist clinic at some point in their illness, patients experience difficulties travelling to clinic as well as the long duration of clinic visits (15, 16) . As they become more frail it often becomes impossible for them to attend the clinic and may lose the benefits offered by the specialist service.
Technologies that enable patients to access health services from their home are now used in many diseases. These include telemedicine (video conferencing), telehealth (remote monitoring of measurements such as oxygen saturations or patient symptoms), telecoaching (mentoring using phone or video) and telecare (technology to support independent living e.g. falls monitors). Other expanding areas include health ÒappsÓ, internet based education, peer support and the storage and sharing of medical records (17) (18) (19) . Video conferencing has been used in neurology outpatient A small number of studies using telehealth in chronic disease (e.g. asthma and heart disease) have demonstrated improvements in quality of life but many found little or no benefit (27,28,33,34). Assessment of cost-effectiveness was often limited by incomplete assessment of the cost of the intervention or health resource use (29).
Even when improvements in quality of life were found, the high cost associated with the intervention meant that the cost per quality adjusted life year gained was very large (33,34). 
Results
The search strategy identified 445 academic references, of which 31 full text articles and one conference abstract were reviewed for eligibility ( Figure 1 ). Interventions and study designs were diverse so statistical analysis was not appropriate and narrative synthesis was undertaken. The results are summarised in Tables 1-3 .
Two uses for technology were identified: video conferencing (telemedicine) as an alternative to outpatient appointments and telehealth to monitor and manage patients with respiratory failure. A number of papers describing the use of internet sites for self-diagnosis, education and social networking were excluded as they did not involve communication with a care team (36). Other telemedicine programmes were identified but were excluded from the review as no evaluations had been conducted (37, 38) . No interventions involving carers of those with ALS were identified.
Telemedicine
Four services used videoconferencing (telemedicine) to facilitate case management ( Discussing most aspects of care using telemedicine was acceptable to patients and reduced travel to hospital, but patients still expressed a preference for face-to-face consultations when discussing emotional and psychological topics, including end-ofof-life decisions. Two services in the United States reported that using telemedicine had avoided outpatient visits resulting in patient travel cost savings (41, 42 ). An
Australian study described using telemedicine between a tertiary centre and local community hospitals to facilitate the care of patients living far from the ALS clinic (39) . The Australian telemedicine service focused on symptom control and end-oflife care and enabled contact for an extra year with patients who would otherwise not have been able to access these services.
Telehealth in respiratory failure in ALS

Study characteristics
12 papers were identified together describing five telehealth systems used to intensively manage patients with chronic respiratory failure as an alternative to outpatient appointments. Table 2 and 3 describes the study methods and results. The interventions and studies are described first, following which the clinical, cost and feasibility outcomes are discussed.
Study quality
Only two trials were identified that involved ALS patients comparing telehealth to usual care. Only one was a randomised controlled trial, the author of which was contacted for information about the methods and results (43) . Another trial was 
Tele-assistance in patients with chronic respiratory failure
An Italian rehabilitation service evaluated a complex telehealth system for patients with respiratory failure. Pulse oximetry data was collected and patients were assessed weekly by a respiratory nurse with access to physicians and a 24-hour emergency helpline (46) .
A one-year randomised controlled trial involved 240 patients with chronic respiratory failure, 22 of whom had ALS and 50 of whom had other neurological disorders (43) .
101 patients used non-invasive ventilation and 43 used tracheostomy ventilation. The primary outcome was rate of hospital admissions. Secondary outcomes included mortality, respiratory exacerbations, emergency room admissions and urgent general practitioner calls. Patients were randomised to usual care (routine three-monthly hospital appointments) or to the telehealth service with no scheduled outpatient appointments.
A five-year observational study of this telehealth service examined the staffing and financial impact of caring for 396 patients, 91 of whom had ALS (47) . Two papers (48, 49) . It is unclear whether the same patients were involved in more than one of these studies. These evaluations estimated the resources required to run the service and potential health resource savings.
The same Italian telehealth system was used to monitor 39 patients with ALS to identify respiratory exacerbations which would trigger the provision of a mechanical insufflation-exsufflation device ÒCough AssistÓ (50) . 12 patients with ALS received cough assist on 47 occasions. The same group conducted a pilot study using longterm monitoring of peak cough flow, oxygen saturations and symptoms to identify respiratory deterioration in 12 patients with ALS using non-invasive ventilation (51).
The patient recorded these measures daily and reported bi-weekly via a telephone call to a physiotherapist.
Home telemonitoring of non-invasive ventilation in patients with amyotrophic lateral sclerosis.
A telehealth service based in Lisbon (Portugal) caring for ALS patients used telehealth in addition to usual clinics using data collected from NIV ventilators relayed to the clinical team via the internet. A set of algorithms were developed to enable clinicians assess patients and schedule telephone calls or hospital visits (52) .
Forty patients with ALS commencing non-invasive ventilation were recruited into a pilot trial and economic evaluation prior to developing respiratory failure (44, 45) .
The intervention was commenced when they started using NIV. Primary outcomes were number of visits to hospital and number of ventilator setting changes needed to reach full compliance. Whilst the trial was described as randomised, patients were assigned a study arm according to whether they lived within Lisbon (usual hospital appointments) or outside Lisbon (intervention: telehealth plus usual three monthly appointments) (44) . Furthermore, whilst limited clinical characteristics collected at baseline suggested the groups were similar, baseline health resource use, socioeconomic status and co-morbid diseases were not reported.
Other feasibility studies
Two other systems used telehealth to manage patients with ALS using NIV were described in feasibility studies. Both services were felt to be feasible and acceptable to patients but no comparative trials of the services were identified (53, 54) . 
Outcomes
Clinical outcomes
The Italian randomised controlled trial of 240 patients (22 of whom had ALS)
reported that telehealth care was associated with significantly fewer hospitalisations, respiratory exacerbations and urgent calls to general practitioners (43) . Mortality and emergency room attendance rates did not differ significantly (43) . These differences only reached significance in the group of patients with chronic obstructive pulmonary disease and no significant differences were detected in the 22 patients with ALS (although the study was not powered to detect a difference in this sub-group) (43).
The Lisbon pilot trial reported that telehealth was associated with significantly fewer outpatient, emergency room and hospital visits, but conclusions should be made with caution given the limitations in methodology (44, 45) . There was a trend towards longer survival in the telehealth group, but median time between symptom onset and starting NIV was much longer in the telehealth group suggesting that these patients had a slower disease course than those in the control group. Therefore these results may be due survival trend to baseline differences between the groups rather than any impact from the intervention.
Cost
The Italian randomised controlled trial was not powered to provide a cost-evaluation.
They did suggested that given the significant reduction in hospitalisations in the telehealth group, the healthcare costs for patients using telehealth would be less, but Half of all cost savings were due to a small difference in the low number of intensive care admissions (14 vs. 16) (43) . Given that there were no significant differences in outcomes in the ALS patients no cost savings were demonstrated (43) . However, according to the five year analysis, cost savings were made as nurses took over the roles of physicians with one nurse able to manage a caseload of 25 patients costing an estimated !105-108 per patient per month (47, 49) . Cost savings were also reported when the same telehealth system was used to detect respiratory exacerbations to supply Cough Assist machines (50) . The service was reported to have prevented 30
hospital admissions which was estimated to be 59% cheaper than providing machines to all patients (50).
In the Lisbon study (after adjusting for survival by dividing the total health costs by the number of days using NIV) healthcare costs in the telehealth group were significantly lower due to reduced inpatient and transport costs (44, 45) . These results should be interpreted with caution as baseline characteristics differed and patients were assigned a study arm based on whether they lived in a rural or urban location -a factor that may independently influence health resource use.
Quality of life, feasibility, acceptability and adherence
None of the studies examined patient or carer burden or quality of life. The Lisbon study examined patientsÕ attitudes to the service: 93% of patients rating the service as ÒgoodÓ or Òvery goodÓ but only 36% of patients considered it to be a method of improving their life (48) . The reasons for this are not described, but these telehealth regimes were very intensive requiring patients to make frequent contact with the ALS team. The Italian study found that the majority of contacts were routine and did not result in a change in their care which may be demoralising to service users (49).
Dropout was low, but the author of the Italian study suggested (in personal correspondence) that it was difficult to recruit ALS patients to the Italian trial because they wanted to use the telehealth service and did not wish to be randomised to the control arm (43, 55) .
Despite the intensity of the regimes, factors that might influence patient adherence were not explored. Poor patient adherence impacted on the success of the service in the telehealth system monitoring cough to detect respiratory exacerbations. The system was so complex for the patients that they failed to adhere to the telehealth regime and did not provide sufficient readings for the system to detect a change in their condition (51) . In another feasibility study using telehealth to support NIV use, those who adhered well to the telehealth regime experienced a reduction in hospitalisations, whereas those who failed to send data regularly experienced an increase in hospitalisations (54) . This requires further investigation as baseline hospitalisation rates were much higher in the ÒgoodÓ adherence group compared to the ÒpoorÓ group and no account was taken of other factors associated with compliance that may independently influence patient outcome (e.g. disease severity).
Discussion
There is limited evidence to recommend the use of telemedicine or telehealth in the care of patients with ALS. However, larger evaluations of telemedicine in other neurological diseases do suggest that telemedicine could be an acceptable alternative to face-to-face consultation, particularly when travelling to clinic is difficult (21,56- Telemedicine could provide access to specialist services between visits such as counselling or speech therapy or by completing some of the consultation at home thus reducing the duration of clinic visits.
With technology costs falling, if interventions do reduce health resource use they could be cost effective. The models of telehealth described in this review are intensive and require a large number of specialist staff at considerable cost, but monitoring could become more automated, reducing staff burden and making systems more affordable. (59, 60) .
Conclusion
Development of successful tele-services requires a better understanding of the beneficial aspects of the traditional ALS services and how these could be delivered using technology. There is currently limited evidence to suggest that using telehealth or telemedicine to improve access to specialist care in ALS improves outcomes or reduces costs. However, the inherent challenges of managing patients with ALS is a reason to support further exploration of how to successfully incorporate technology into ALS specialist services. Any future studies should ensure that all relevant impacts of such technology interventions are captured, enabling successful evaluation and when appropriate, future implementation. 
